Items where Author is "Angelis, Aris"

Number of items: 6.
2022
  • Understanding the socioeconomic costs of dystrophic epidermolysis bullosa in Europe: a costing and health-related quality of life study. (2022) Angelis, A; Mellerio, JE; Kanavos, P
  • Funding Sources of Therapeutic and Vaccine Clinical Trials for COVID-19 vs Non-COVID-19 Indications, 2020-2021. (2022) Angelis, Aris; Suarez Alonso, Carlos; Kyriopoulos, Ilias; Mossialos, Elias
    • 2021
  • Evidence generation and reproducibility in cell and gene therapy research: A call to action. (2021) Abou-El-Enein, Mohamed; Angelis, Aris; Appelbaum, Frederick R; Andrews, Nancy C; Bates, Susan E; Bierman, Arlene S; Brenner, Malcolm K; Cavazzana, Marina; Caligiuri, Michael A; Clevers, Hans; Cooke, Emer; Daley, George Q; Dzau, Victor J; Ellis, Lee M; Fineberg, Harvey V; Goldstein, Lawrence SB; Gottschalk, Stephen; Hamburg, Margaret A; Ingber, Donald E; Kohn, Donald B; Krainer, Adrian R; Maus, Marcela V; Marks, Peter; Mummery, Christine L; Pettigrew, Roderic I; Rutter, Joni L; Teichmann, Sarah A; Terzic, Andre; Urnov, Fyodor D; Williams, David A; Wolchok, Jedd D; Lawler, Mark; Turtle, Cameron J; Bauer, Gerhard; Ioannidis, John PA
  • Safeguarding evidence-based decision making in the FDA for COVID-19 vaccines. (2021) Angelis, Aris; Darrow, Jonathan
    • 2020
  • Advancing structured decision-making in drug regulation at the FDA and EMA. (2020) Angelis, Aris; Phillips, Lawrence D
  • Early Health Technology Assessment during Nonalcoholic Steatohepatitis Drug Development: A Two-Round, Cross-Country, Multicriteria Decision Analysis. (2020) Angelis, Aris; Thursz, Mark; Ratziu, Vlad; O'Brien, Alastair; Serfaty, Lawrence; Canbay, Ali; Schiefke, Ingolf; Costa, Joao Bana E; Lecomte, Pascal; Kanavos, Panos